Vanguard Group Inc Calyxt, Inc. Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.13 - $0.2 $12,078 - $18,582	-92,914 Reduced 32.58%	192,274 $28,000
Q3 2022 Nov 14, 2022	BUY	$0.17 - $0.3 $2,102 - $3,709	12,366 Added 4.53%	285,188 $49,000
Q1 2022 May 13, 2022	SELL	$1.02 - $2.46 $265,150 - $639,479	-259,951 Reduced 48.79%	272,822 $284,000
Q4 2021 Feb 14, 2022	SELL	$2.06 - $4.05 $34,082 - $67,007	-16,545 Reduced 3.01%	532,773 $1.14 Million
Q3 2021 Nov 12, 2021	BUY	$3.18 - $5.08 $4,041 - $6,456	1,271 Added 0.23%	549,318 $1.85 Million
Q2 2021 Aug 13, 2021	BUY	$3.83 - $6.31 $2.1 Million - $3.46 Million	548,047 New	548,047 $2.2 Million

Ticker CLXT
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 46,792,100
Market Cap $913M
Description
Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the excl...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.